Latest Blog Posts

FDA issues drug warning

by fpw | September 18th, 2008

September 18, 2008 The Food and Drug Administration issued a warning to the Republic of Indiana regarding drugs from Ranbaxy Laboratories, Ltd. due to noncompliance with FDA standards which could lead to drug injuries. The warning comes after the FDA became concerned with U.S. current Good Manufacturing Practices at the plant which produces generic drugs.

Read More

Clinical study finds Rituxan could cause drug injuries and death

by fpw | September 16th, 2008

September 16, 2008 The FDA reported that Genentec issued a warning to health care professionals regarding prescribing information for Rituxan, which was linked in a clinical study to the death of a patient who sustained drug injuries as a result of taking the drug. The drug injury victim, who had rheumatoid arthritis and was taking

Read More

FDA warns about Bystolic’s potential for drug injuries

by fpw | September 11th, 2008

September 11, 2008 The FDA is warning Forest Laboratories about its promotion of the hypertension drug Bystolic. The FDA says the promotions for Bystolic have failed to include risks for certain drug injuries. The promotions for the new drug claim that the drug is better than rival drugs, but there is not sufficient evidence to

Read More

20 medications may be associated with drug injuries

by fpw | September 9th, 2008

September 9, 2008 The Associated Press reported that the FDA has released a list of 20 medications that may pose safety concerns such as potential drug injuries for patients. However, some worry that this list of medications, which does not provide specific information regarding the potential drug injuries or safety concerns of the medications on

Read More